Evidence map›Paper›PMID 38824644›Full record

ArticleCell reports2024

Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue.

Roberta I Lock, Pamela L Graney, Daniel Naveed Tavakol, Trevor R Nash, Youngbin Kim, Eloy Sanchez, Margaretha Morsink, Derek Ning, Connie Chen, Sharon Fleischer and 2 more

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Review
  3. A practical toolbox for modelling fibrosis in vitro.Nature biomedical engineering · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Coordination of cardiogenesis in vivo and in vitro.Nature reviews. Molecular cell biology · 2026
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Roberta I LockDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Pamela L GraneyDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Daniel Naveed TavakolDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Trevor R NashDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Youngbin KimDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Eloy SanchezDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Margaretha MorsinkDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Derek NingDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Connie ChenDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Sharon FleischerDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Ilaria BaldassarriDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
Gordana Vunjak-NovakovicDepartment of Biomedical Engineering, Columbia University, New York, NY 10027, USA; Department of Medicine, Columbia University, New York, NY 10032, USA; College of Dental Medicine, Columbia University, New York, NY 10032, USA. Electronic address: gv2131@columbia.edu.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
Engineering Vascularized Cardiac MuscleR01HL076485 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Gordana Vunjak-Novakovic · 2005 to 2026
$9.2M
Cancer Patient on a ChipR01CA249799 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2020 to 2026
$3.1M
NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA249799NHLBI NIH HHS R01 HL076485NIBIB NIH HHS P41 EB027062
6 · The paper itself

Abstract

Resident cardiac macrophages are critical mediators of cardiac function. Despite their known importance to cardiac electrophysiology and tissue maintenance, there are currently no stem-cell-derived models of human engineered cardiac tissues (hECTs) that include resident macrophages. In this study, we made an induced pluripotent stem cell (iPSC)-derived hECT model with a resident population of macrophages (iM0) to better recapitulate the native myocardium and characterized their impact on tissue function. Macrophage retention within the hECTs was confirmed via immunofluorescence after 28 days of cultivation. The inclusion of iM0s significantly impacted hECT function, increasing contractile force production. A potential mechanism underlying these changes was revealed by the interrogation of calcium signaling, which demonstrated the modulation of β-adrenergic signaling in +iM0 hECTs. Collectively, these findings demonstrate that macrophages significantly enhance cardiac function in iPSC-derived hECT models, emphasizing the need to further explore their contributions not only in healthy hECT models but also in the contexts of disease and injury.

Indexed as

Induced Pluripotent Stem CellsMacrophagesMyocardial ContractionTissue EngineeringCalcium SignalingCell DifferentiationHumansMyocardiumMyocytes, CardiaccardiacCP: Developmental biologyimmuneiPSCmacrophagemyocardiumstem celltissue engineering

Identifiers

PMID38824644
PMCPMC11254687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.